As of 4:00pm ET
| -0.05 / -1.90%|
The 3 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 3.50, with a high estimate of 4.50 and a low estimate of 3.25. The median estimate represents a +35.66% increase from the last price of 2.58.
The current consensus among 6 polled investment analysts is to Hold stock in Pacific Biosciences of California Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.